A Study to Evaluate the Safety and Pharmacokinetics of AD-221 Compared to Coadministration of AD-221A and AD-221B

Clinical trial NCT05202405 · COMPLETED

Trial details

NCT number: NCT05202405
Sponsor: Addpharma Inc.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Hyperlipidemias

Start date: 2022-01-05
Primary completion: 2022-03-04
Enrollment: 64

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.